Northern Trust’s Trillium Therapeutics Inc. TRIL Stock Holding History

Northern Trust’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-772,019	Closed	-$13.6M	–	4835
2021 Q3	$13.6M	Sell	772,019 -31,610	-4%	-$369K	﹤0.01%	2066
2021 Q2	$7.8M	Buy	+803,629	New	+$7.56M	﹤0.01%	2546
2021 Q1	–	Sell	-36,345	Closed	-$535K	–	4519
2020 Q4	$535K	Sell	36,345 -883	-2%	-$12.7K	﹤0.01%	3711
2020 Q3	$529K	Buy	+37,228	New	+$371K	﹤0.01%	3594

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Northern Trust's TRIL Position: Q4 2021 in Review

Northern Trust sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 772,019 shares — an estimated $13.6M sold.

Northern Trust first reported a position in TRIL in Q3 2020 and held it in 4 quarters. The position peaked at $13.6M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Northern Trust reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Northern Trust sold 772,019 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $13.6M.
Northern Trust first reported a position in Trillium Therapeutics Inc. in Q3 2020 and held it in 4 quarters.
Northern Trust's Trillium Therapeutics Inc. position peaked at $13.6M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Northern Trust's 13F filing for Q4 2021, filed 8 Feb 2022.